STTR Phase I: Commercial Cell-Free Technology for IGF-1 Production

Fundamental Applied Biology, Inc., Menlo Park CA

Investigators

Abstract

This Small Business Technology Transfer (STTR) Phase I project proposes to develop a cell free protein synthesis procedure for the manufacture of IGF-1 (insulin-like growth factor-1). The commercial application of this project will be in the area of bio-pharmaceuticals. The proposed work is expected to result in reduced production costs and time for a number of protein drug candidates.